Stock Financial Ratios

RARX / Ra Pharmaceuticals, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Market Cap ($M)60.38
Enterprise Value ($M)-36.23
Book Value ($M)117.22
Book Value / Share28.35
Price / Book0.52
NCAV ($M)120.08
NCAV / Share29.04
Price / NCAV3.79
Income Statement (mra) ($M)
Net Income-28.86
Balance Sheet (mrq) ($M)
Cash & Equivalents84.09
Cash / Share20.33
Quick Ratio17.74
Current Ratio17.74
Management Effectiveness (mra)
Return on Invested Capital (ROIC)-0.25
Return on Assets (ROA)-0.23
Return on Equity (ROE)-0.25
Identifiers and Descriptors
Central Index Key (CIK)1481512
Industry Groups
Share Statistics
Common Shares Outstanding (M)22.63
Scoring Models
Piotroski F Score2.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Kaplan-Zingales KZ-IndexN/A
Cash Conversion CycleN/A
Per Share Metrics
Inventory Work In Progress Per Share0.00
Equity Per Share19.97
Accumulated Depreciation And Depletion Per Share0.79
Long Term Debt Per Share0.00
Liabilities And Stock Equity Per Share22.47
Treasury Stock Per Share0.00
Cash Per Share20.33
Liabilities Current Per Share1.89
Debt Per Share0.00
Deferred Income Tax Liabilities Per Share0.00
Additional Paid In Capital Per Share46.10
Liabilities Per Share2.50
Assets Other Non Current Per Share0.00
Liabilities Other Non Current Per Share0.00
Assets Current Per Share20.61
Property Plant And Equipment Per Share1.44
Retained Earnings Per Share-26.13
Minority Interest Per Share0.00
Current Portion Of Long Term Debt Per Share0.00
Goodwill Per Share0.04
Accounts Receivable Per Share0.00
Intangibles Per Share0.05
Assets Per Share22.47
Inventory Raw Materials Per Share0.00
Cash And Equivalents Per Share20.33
Assets Other Current Per Share0.00
Accounts Payable Per Share0.00
Inventory Finished Goods Per Share0.00
Preferred Stock Value Outstanding Per Share0.00
Assets Non Current Per Share0.00
Inventory Per Share0.00
Property Plant And Equipment Gross Per Share2.23
Property Plant And Equipment Net Per Share1.44

Related News Stories

Waiting For A Pullback In Alexion Pharmaceuticals

2017-08-15 seekingalpha
Today we look at mid-cap biotech concern Alexion Pharmaceuticals which recently delivered better than expected quarterly results.

Unshakeable Alexion Sees Off Ra And Akari

2017-06-28 seekingalpha
Perhaps the most astonishing thing about Ra Pharmaceuticals' (NASDAQ:RARX) phase II study of RA101495 for the rare disease paroxysmal nocturnal hemoglobinuria is that the company was able to find three subjects who had not already received Alexion's (NASDAQ:ALXN) Soliris. (0-1)

Here's Why Ra Pharmaceuticals Inc. Tumbled as Much as 32% Today

2017-06-27 fool
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. (0-2)

CUSIP: 74933V108